MDM2 promoter SNP309 is associated with the risk of hepatocellular carcinoma in patients with chronic hepatitis C (Q80129017)
Jump to navigation
Jump to search
scientific article published on 01 August 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | MDM2 promoter SNP309 is associated with the risk of hepatocellular carcinoma in patients with chronic hepatitis C |
scientific article published on 01 August 2006 |
Statements
MDM2 promoter SNP309 is associated with the risk of hepatocellular carcinoma in patients with chronic hepatitis C (English)
Narayan Dharel
Naoya Kato
Ryosuke Muroyama
Masaru Moriyama
Run-Xuan Shao
Takao Kawabe
1 August 2006